Back to Trades
Trade Summary
On Sep 1, 2026, Dittrich Thomas J.W., EVP & CFO, reported $NaN of AMGEN INC (AMGN) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Insider Information
- Role
- EVP & CFO
- Location
- THOUSAND OAKS, CA
Filing Details
- Filing Date
- Sep 4, 2026
- Transaction Date
- Sep 1, 2026
- Accession Number
- 0000318154-26-000139
- Form Type
- 3
Want live alerts when Dittrich Thomas J.W. trades again?
Download Insider Trades to track AMGN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- (F2)These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027.